Recursion Pharmaceuticals (RXRX) EPS (Basic) (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Recursion Pharmaceuticals | 2.01 Bn | 1.35 Bn | -6.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.41% |
| Dec 31, 2025 | 52.78% |
| Sep 30, 2025 | 12.20% |
| Jun 30, 2025 | 18.00% |
| Mar 31, 2025 | 12.28% |
| Dec 31, 2024 | -67.65% |
| Sep 30, 2024 | 15.00% |
| Jun 30, 2024 | -2.56% |
| Mar 31, 2024 | 7.14% |
| Dec 31, 2023 | 2.33% |
| Sep 30, 2023 | -13.16% |
| Jun 30, 2023 | -11.76% |
| Mar 31, 2023 | -13.33% |
| Dec 31, 2022 | 14.29% |
| Sep 30, 2022 | 7.89% |
| Jun 30, 2022 | -15.15% |
| Mar 31, 2022 | 15.38% |
| Dec 31, 2021 | -39.29% |
| Sep 30, 2021 | 9.68% |
| Jun 30, 2021 | 76.69% |
| Mar 31, 2021 | -13.68% |
| Dec 31, 2020 | -7.34% |
| Sep 30, 2020 | -23.86% |
| Jun 30, 2020 | -3.53% |